Transcription of Essential IND Strategies: Fundamental Considerations on ...
{{id}} {{{paragraph}}}
Essential IND Strategies: Fundamental Considerations on the Road to Success Darren Warren drug Discovery & Development Target Identification HTS (High Throughput Screening) Actives to Hits Hit to Lead Lead Optimization (SAR) Preclinical Candidate IND Enabling & Registration Support Studies Clinical Candidate NDA Phase I - III Market Introduction Phase IV API Synthesis, Analytical & Scale-up Focus of Today s Discussion Early Clinical Goals & Regulatory Strategy 1)Define drug development goals: Identify target patient population, rationale for clinical need, & initial region for clinical development. Goal should not simply be to file an IND, rather develop a drug therapy 2)Initial clinical trials designed to characterize: Human DMPK, safety, pharmacologic activity & proof of concept 3)Understand regulatory guidelines and precedented approaches for similar drugs (same chemical class & indication or relevant) 4)Chemical development
drug formulations, with well characterized impurity profiles. 5) ... Does not address potential genotoxic impurities in API Genetic Toxicology . Requirements ICH Core Battery: ... Small molecule – commonly stand alone studies Biological – …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}